What Researchers Did
Researchers retrospectively reviewed the clinical value of hyperbaric oxygen therapy for major wounds and fistulas in 16 head and neck cancer patients who underwent salvage surgery after (chemo)radiation.
What They Found
Hyperbaric oxygen therapy appeared to initiate and accelerate healing processes in patients with non-healing wounds after head and neck salvage surgery. Specifically, 14 of the 16 (87.5%) patients treated with hyperbaric oxygen therapy achieved complete wound healing, with no life-threatening complications reported.
What This Means for Canadian Patients
Canadian patients undergoing salvage surgery for head and neck cancer after radiation or chemoradiation may benefit from hyperbaric oxygen therapy for non-healing wounds. This therapy could offer a practical approach to improve wound healing outcomes and potentially reduce the burden of complications in this vulnerable population.
Canadian Relevance
This study has no direct Canadian connection as it was not conducted in Canada, nor did it involve Canadian researchers or participants.
Study Limitations
Key limitations include the retrospective design and the very small sample size of only 16 patients, which limits the generalizability of the findings.